A machine learning model that emulates experts’ decision making in vancomycin initial dose planning

A machine learning model that emulates experts’ decision making in vancomycin initial dose planning

Vancomycin is a glycopeptide antibiotic that is a primary treatment for methicillin-resistant Staphylococcus aureus infections. To enhance its clinical effectiveness and prevent nephrotoxicity, therapeutic drug monitoring (TDM) of trough concentrations is recommended.Initial vancomycin dosing regime...

Full description

Bibliographic Details
Main Authors:	Tetsuo Matsuzaki, Yoshiaki Kato, Hiroyuki Mizoguchi, Kiyofumi Yamada
Format:	Article
Language:	English
Published:	Elsevier 2022-04-01
Series:	Journal of Pharmacological Sciences
Subjects:	Machine learning Vancomycin Initial dosing regimen MRSA TDM
Online Access:	http://www.sciencedirect.com/science/article/pii/S1347861322000184

Similar Items

Reappraisal of therapeutic vancomycin trough concentrations with empirical dosing in neonatal infections
by: Tzung-Yi Lee, et al.
Published: (2023-03-01)

Prospective validation of neonatal vancomycin dosing regimens is urgently needed
by: Anaïs Vandendriessche, MD, et al.
Published: (2014-12-01)

Vancomycin Revisited - 60 years later
by: Ethan eRubinstein, et al.
Published: (2014-10-01)

The impact of Vancomycin loading dose on the emergency department in Saudi Arabia: a multicenter cohort study
by: Waad H. Al-Kathiri, et al.
Published: (2021-12-01)

Efficacy of prolonged tapered and pulsed vancomycin regimen on recurrent Clostridioides difficile infection in the Japanese setting: a case control study
by: Takumi Umemura, et al.
Published: (2019-08-01)

The pharmacokinetics of vancomycin during the initial loading dose in patients with septic shock
by: Katip W, et al.
Published: (2016-11-01)

Standard of Care Not Met? Monitoring and Dosing of Vancomycin is Error-Prone
by: Ashton C. Lai, et al.
Published: (2020-07-01)

Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model
by: Kashif Hussain, et al.
Published: (2021-12-01)

Vancomycin AUC-Based Dosing Practices in a Non-Teaching Community Hospital and Associated Outcomes: A One-Year Survey of Uniform Targets for Infections with or without MRSA
by: Iftekharul Islam
Published: (2024-01-01)

Vancomycin Utilization Evaluation: Are We Dosing Appropriately?
by: Ladan Ayazkhoo, et al.
Published: (2015-10-01)

Real-Life Vancomycin Therapeutic Drug Monitoring in Coagulase-Negative Staphylococcal Bacteremia in Neonatal and Pediatric Intensive Care Unit: Are We Underestimating Augmented Renal Clearance?
by: Claudia Sette, et al.
Published: (2023-10-01)

Vancomycin Loading Doses and Nephrotoxicity on Medicine Teaching Services
by: Wagner P, et al.
Published: (2022-10-01)

Prediction of vancomycin initial dosage using artificial intelligence models applying ensemble strategy
by: Wen-Hsien Ho, et al.
Published: (2023-03-01)

A simple and validated HPLC method for vancomycin assay in plasma samples: the necessity of TDM center development in Southern Iran
by: Parisa Ghasemiyeh, et al.
Published: (2020-01-01)

Occurrence of vancomycin MIC creep in methicillin resistant isolates in Saudi Arabia
by: Sameerah Aljohani, et al.
Published: (2020-10-01)

Optimization of Initial Dose Regimen for Sirolimus in Pediatric Patients With Lymphangioma
by: Xiao Chen, et al.
Published: (2021-11-01)

Development of a decision flowchart to identify the patients need high-dose vancomycin in early phase of treatment
by: Ryo Yamaguchi, et al.
Published: (2022-01-01)

Evidence from an In Vitro Study: Is Oxacillin Plus Vancomycin a Better Choice for Heteroresistant Vancomycin-Intermediate Staphylococcus aureus?
by: Yamuna Devi Bakthavatchalam, et al.
Published: (2018-11-01)

VANCOMYCIN SENSITIVITY OF Staphylococcus aureus ISOLATES FROM HOSPITAL PATIENTS IN KARACHI, PAKISTAN
by: Javaid SG, et al.
Published: (2007-01-01)

Empiric guideline-recommended weight-based vancomycin dosing and mortality in methicillin-resistant <it>Staphylococcus aureus bacteremia: a retrospective cohort study</it>
by: Hall Ronald G, et al.
Published: (2012-04-01)

A descriptive study of vancomycin use at Red Cross War Memorial Children’s Hospital, Cape Town
by: Leonore Greybe, et al.
Published: (2023-11-01)

Stability Evaluation of Extemporaneously Compounded Vancomycin Ophthalmic Drops: Effect of Solvents and Storage Conditions
by: Christopher Ross, et al.
Published: (2021-02-01)

The Evolving Reduction of Vancomycin and Daptomycin Susceptibility in MRSA—Salvaging the Gold Standards with Combination Therapy
by: Taylor Morrisette, et al.
Published: (2020-10-01)

Addition of vancomycin to cefazolin is often unnecessary for preoperative antibiotic prophylaxis during total joint arthroplasties
by: Sandeep S. Bains, et al.
Published: (2024-03-01)

Population Pharmacokinetics and Model-Based Dose Optimization of Vancomycin in Sudanese Adult Patients with Renal Impairment
by: Ahmed KA, et al.
Published: (2024-01-01)

Subtherapeutic Doses of Vancomycin Synergize with Bacteriophages for Treatment of Experimental Methicillin-Resistant <i>Staphylococcus aureus</i> Infective Endocarditis
by: Jonathan Save, et al.
Published: (2022-08-01)

Vancomycin-intermediate livestock-associated methicillin-resistant Staphylococcus aureus ST398/t9538 from swine in Brazil
by: Luisa Z Moreno, et al.

A Systematic Review on Clinical Safety and Efficacy of Vancomycin Loading Dose in Critically Ill Patients
by: Abdul Haseeb, et al.
Published: (2022-03-01)

Time-dependent efficacy of combination of silver-containing hydroxyapatite coating and vancomycin on methicillin-resistant Staphylococcus aureus biofilm formation in vitro
by: Akira Hashimoto, et al.
Published: (2021-03-01)

Enteral Vancomycin to Eliminate MRSA Carriership of the Digestive Tract in Critically Ill Patients
by: Sophie H. Buitinck, et al.
Published: (2022-02-01)

Continuous-Infusion Vancomycin in Neonates: Assessment of a Dosing Regimen and Therapeutic Proposal
by: Manon Tauzin, et al.
Published: (2019-05-01)

Dose optimization of vancomycin in obese patients: A systematic review
by: Mahmoud E. Elrggal, et al.
Published: (2023-03-01)

Preparation and in vivo evaluation of nanoliposomes containing vancomycin after intravitreal injection in albino rabbits
by: Majid Abrishami, et al.
Published: (2020-04-01)

Association between cell growth and vancomycin resistance in clinical community-associated methicillin-resistant Staphylococcus aureus
by: Yamaguchi T, et al.
Published: (2019-08-01)

Vancomycin Intermediate MRSA Isolates Obtained from Retail Chicken Meat and Eggs Collected at Pokhara, Nepal
by: Surya Prasad Devkota, et al.
Published: (2019-12-01)

Molecular characterisation and epidemiology of transmission of intraoperative Staphylococcus aureus isolates stratified by vancomycin minimum inhibitory concentration (MIC)
by: Brent Hadder, et al.
Published: (2022-12-01)

Bridging the Gap between Theory and Practice; the Active Role of Inpatient Pharmacists in Therapeutic Drug Monitoring
by: Abrar F Alhameed, et al.
Published: (2019-02-01)

Effects of caspofungin, tolcapone and other FDA-approved medications on MRSA susceptibility to vancomycin
by: Jonah A. Moore, et al.
Published: (2020-09-01)

A Retrospective Study on the Effectiveness and Safety of Vancomycin versus Daptomycin in Hemodialysis Patients
by: Hideo Kato, et al.
Published: (2022-05-01)

Assessment of Initial Vancomycin Dosing in Pediatric Oncology Patients
by: Hillary Orr, et al.
Published: (2017-08-01)